In subcutaneous tumor models of diverse tumors, unlike the responses to PD-1, PD-L1 and CTLA-4 inhibitors or other cytokines, TRIM3 mRNA expression decreased specifically upon IFN-β stimulation in the LLC lung cancer model (Fig. 1D, E). This evidence concerns the gene TRIM3 and lung carcinoma.